Variant report
Variant | esv3482641 |
---|---|
Chromosome Location | chr12:10721163-10723011 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr12:10722202..10724547-chr12:10764643..10766915,2 | K562 | blood: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000111196 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs184717943 | chr12:10721175-10721176 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs373308340 | chr12:10721188-10721189 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs552543533 | chr12:10721223-10721224 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs546415632 | chr12:10721272-10721273 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs189648380 | chr12:10721276-10721277 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs535127615 | chr12:10721306-10721307 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs10845166 | chr12:10721348-10721349 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs568780727 | chr12:10721379-10721380 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs113905968 | chr12:10721424-10721425 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs201456329 | chr12:10721425-10721426 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs372595138 | chr12:10721427-10721428 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs4763555 | chr12:10721456-10721457 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
13 | rs180693643 | chr12:10721467-10721468 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs552795333 | chr12:10721472-10721473 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs200906389 | chr12:10721514-10721515 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs577553257 | chr12:10721587-10721588 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs185731266 | chr12:10721591-10721592 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs569520382 | chr12:10721684-10721685 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs4763556 | chr12:10721686-10721687 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs573160456 | chr12:10721754-10721755 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs370871435 | chr12:10721767-10721768 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs73058241 | chr12:10721787-10721788 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs561605541 | chr12:10721829-10721830 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs530713330 | chr12:10721846-10721847 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs150445353 | chr12:10721847-10721848 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs569626923 | chr12:10721891-10721892 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs4763557 | chr12:10721915-10721916 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
28 | rs533010318 | chr12:10721961-10721962 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs189204321 | chr12:10722048-10722049 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs181600845 | chr12:10722102-10722103 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs138274169 | chr12:10722163-10722164 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs78141846 | chr12:10722176-10722177 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs185965064 | chr12:10722179-10722180 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs537731678 | chr12:10722197-10722198 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs557720275 | chr12:10722216-10722217 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs113969302 | chr12:10722234-10722235 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs77667704 | chr12:10722266-10722267 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
38 | rs534090908 | chr12:10722273-10722274 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
39 | rs539663731 | chr12:10722324-10722325 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
40 | rs190430285 | chr12:10722358-10722359 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
41 | rs374479868 | chr12:10722421-10722422 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs573264232 | chr12:10722425-10722426 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs141375859 | chr12:10722442-10722443 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
44 | rs59257057 | chr12:10722449-10722450 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs181560807 | chr12:10722509-10722510 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
46 | rs544082199 | chr12:10722517-10722518 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
47 | rs34926964 | chr12:10722543-10722544 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
48 | rs536962128 | chr12:10722550-10722551 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs7978850 | chr12:10722585-10722586 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
50 | rs571016022 | chr12:10722623-10722624 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 17690704 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Ovine squamous-cell carcinoma | 17599052 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
T-cell acute lymphoblastic leukemia | 20065082 | CNVD |
Breast cancer | 22032731 | CNVD |
Cancer | 21183584 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Prostate cancer | 21965145 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Liposarcoma | 21253554 | CNVD |
Prostate cancer | 19156837 | CNVD |
Emphysema | 19352772 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Malignant germ cell tumour | 17285132 | CNVD |
Melanoma | 18172304 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Wilms tumour | 21544195 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Breast cancer | 21264507 | CNVD |
Cancer | 16751803 | CNVD |
Testicular cancer | 18059402 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Seminomas | 18059402 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Malaria | 21533027 | CNVD |
Chronic lymphocytic leukemia | 22228453 | CNVD |
Chronic lymphocytic leukemia | 21670202 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Breast cancer | 21858162 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 21785460 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Autism | 22495311 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21364760 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Breast cancer | 21611746 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Lung cancer | 18438408 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Cutaneous T-cell lymphoma | 21881587 | CNVD |
Squamous cell cancer | 19607727 | CNVD |
Prostate cancer | 16573809 | CNVD |
T-cell acute lymphoblastic leukemia | 19406988 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Acute lymphoblastic leukemia | 19100363 | CNVD |
Acute myeloid leukemia | 17268525 | CNVD |
Acute monocytic leukemia | 16498392 | CNVD |
Prostate cancer | 16461572 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Breast cancer | 17133270 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr12:10710800-10724800 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
2 | chr12:10714000-10733200 | Weak transcription | Primary T cells from cord blood | blood |
3 | chr12:10716800-10723800 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
4 | chr12:10717800-10721600 | Enhancers | Primary T killer naive cells fromperipheralblood | blood |
5 | chr12:10722400-10722600 | Enhancers | HUES6 Cell Line | embryonic stem cell |
6 | chr12:10722400-10722600 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
7 | chr12:10722600-10723600 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
8 | chr12:10722600-10723800 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
9 | chr12:10722800-10723000 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
10 | chr12:10723000-10723800 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |